GB201521357D0 - Methods for predicting response to anti-TNF therapy - Google Patents

Methods for predicting response to anti-TNF therapy

Info

Publication number
GB201521357D0
GB201521357D0 GBGB1521357.2A GB201521357A GB201521357D0 GB 201521357 D0 GB201521357 D0 GB 201521357D0 GB 201521357 A GB201521357 A GB 201521357A GB 201521357 D0 GB201521357 D0 GB 201521357D0
Authority
GB
United Kingdom
Prior art keywords
methods
predicting response
tnf therapy
tnf
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1521357.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Priority to GBGB1521357.2A priority Critical patent/GB201521357D0/en
Publication of GB201521357D0 publication Critical patent/GB201521357D0/en
Priority to JP2018529050A priority patent/JP2018537100A/ja
Priority to PCT/GB2016/053798 priority patent/WO2017093750A1/en
Priority to CN201680071029.6A priority patent/CN108291261A/zh
Priority to AU2016364003A priority patent/AU2016364003A1/en
Priority to EP16808777.3A priority patent/EP3384044A1/en
Priority to CA3005695A priority patent/CA3005695A1/en
Priority to US15/780,762 priority patent/US20190367984A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Primary Health Care (AREA)
  • Signal Processing (AREA)
  • Biomedical Technology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB1521357.2A 2015-12-03 2015-12-03 Methods for predicting response to anti-TNF therapy Ceased GB201521357D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB1521357.2A GB201521357D0 (en) 2015-12-03 2015-12-03 Methods for predicting response to anti-TNF therapy
JP2018529050A JP2018537100A (ja) 2015-12-03 2016-12-02 抗tnf療法に対する応答を予測する方法
PCT/GB2016/053798 WO2017093750A1 (en) 2015-12-03 2016-12-02 Methods for predicting response to anti-tnf therapy
CN201680071029.6A CN108291261A (zh) 2015-12-03 2016-12-02 用于预测对抗tnf治疗的响应的方法
AU2016364003A AU2016364003A1 (en) 2015-12-03 2016-12-02 Methods for predicting response to anti-TNF therapy
EP16808777.3A EP3384044A1 (en) 2015-12-03 2016-12-02 Methods for predicting response to anti-tnf therapy
CA3005695A CA3005695A1 (en) 2015-12-03 2016-12-02 Methods for predicting response to anti-tnf therapy
US15/780,762 US20190367984A1 (en) 2015-12-03 2016-12-02 Methods for predicting response to anti-tnf therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1521357.2A GB201521357D0 (en) 2015-12-03 2015-12-03 Methods for predicting response to anti-TNF therapy

Publications (1)

Publication Number Publication Date
GB201521357D0 true GB201521357D0 (en) 2016-01-20

Family

ID=55234362

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1521357.2A Ceased GB201521357D0 (en) 2015-12-03 2015-12-03 Methods for predicting response to anti-TNF therapy

Country Status (8)

Country Link
US (1) US20190367984A1 (enExample)
EP (1) EP3384044A1 (enExample)
JP (1) JP2018537100A (enExample)
CN (1) CN108291261A (enExample)
AU (1) AU2016364003A1 (enExample)
CA (1) CA3005695A1 (enExample)
GB (1) GB201521357D0 (enExample)
WO (1) WO2017093750A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108290058B (zh) 2015-09-17 2023-05-16 美国安进公司 使用il23途径生物标志物预测il23拮抗剂的临床应答
WO2019018440A1 (en) * 2017-07-17 2019-01-24 The Broad Institute, Inc. HUMAN COLON CELL ATLAS IN GOOD HEALTH AND WITH HEMORRHAGIC RECTO-COLITIS
CN108047327B (zh) * 2017-11-29 2020-08-07 中国医学科学院北京协和医院 一种检测骨关节炎的生物标志物及其应用
US20200399698A1 (en) * 2018-02-19 2020-12-24 Genefron Ltd. Methods of determining response to tnf alpha blockers
EP3765634A4 (en) 2018-03-16 2021-12-01 Scipher Medicine Corporation METHODS AND SYSTEMS FOR PREDICTING THE RESPONSE TO ANTI-TNF THERAPIES
US20210104321A1 (en) * 2018-11-15 2021-04-08 Ampel Biosolutions, Llc Machine learning disease prediction and treatment prioritization
GB2603294A (en) 2019-06-27 2022-08-03 Scipher Medicine Corp Developing classifiers for stratifying patients
WO2021067667A1 (en) * 2019-10-04 2021-04-08 The Regents Of The University Of Michigan Methods for determining responsiveness to anti-tumor necrosis factor therapy in the treatment of psoriasis
KR20230165746A (ko) * 2020-11-30 2023-12-05 민데라 코포레이션 마이크로니들 디바이스 및 방법, 및 피부 병태 어세이
WO2022190036A2 (en) * 2021-03-12 2022-09-15 Janssen Biotech, Inc. Methods for predicting treatment response in ulcerative colitis
CN113373218A (zh) * 2021-08-04 2021-09-10 杭州浙大迪迅生物基因工程有限公司 一组检测人嗜酸性粒细胞阳离子蛋白mRNA表达的引物组和试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2069533B1 (en) * 2006-07-13 2012-11-07 Life Technologies Corporation Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
WO2008132176A2 (en) * 2007-04-27 2008-11-06 Universite Catholique De Louvain Method for evaluating the response of an individual to tnf blocking therapy
CA2690898A1 (en) * 2007-06-08 2008-12-18 Biogen Idec Ma Inc. Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
EP2192197A1 (en) * 2008-11-27 2010-06-02 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Predicting clinical response to treatment with a soluble tnf-antagonist or tnf, or a tnf receptor agonist
MX353186B (es) * 2009-09-03 2018-01-05 Genentech Inc Metodos para el tratamiento, diagnosis y monitoreo de artritis reumatoide.
US20130042333A1 (en) * 2011-05-06 2013-02-14 Jean-Gabriel JUDDE Markers for cancer prognosis and therapy and methods of use
HU230680B1 (hu) * 2012-10-19 2017-08-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Diagnosztikai eljárás
US9809854B2 (en) * 2012-11-15 2017-11-07 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Biomarkers for disease activity and clinical manifestations systemic lupus erythematosus

Also Published As

Publication number Publication date
CN108291261A (zh) 2018-07-17
US20190367984A1 (en) 2019-12-05
AU2016364003A1 (en) 2018-06-28
JP2018537100A (ja) 2018-12-20
WO2017093750A1 (en) 2017-06-08
EP3384044A1 (en) 2018-10-10
CA3005695A1 (en) 2017-06-08

Similar Documents

Publication Publication Date Title
IL285287A (en) Antibodies to tigit
IL256499A (en) Antibodies to CD40
IL251508A0 (en) Anti-TNF compounds
FI3198035T3 (fi) Menetelmiä lääkevasteen ennustamiseksi
GB201521357D0 (en) Methods for predicting response to anti-TNF therapy
GB201708360D0 (en) Methods for determining health risks
GB2538731B (en) Methods
GB201410262D0 (en) Novel method
IL273265A (en) New combinations for antigen-based therapy
IL251858A0 (en) Enhanced il-6 antagonists
GB201417341D0 (en) Chromatography
IL248697A0 (en) Methods for purifying antibodies
GB201518762D0 (en) Methods
GB201508927D0 (en) Methods
SG11201703801SA (en) Novel methods
SG11201609522TA (en) Methods for treating cardiovascular diseases
GB201515655D0 (en) Methods
EP3164122A4 (en) Predicting response to cancer therapy
GB201411567D0 (en) Quantification methods
GB201416773D0 (en) Novel Methods For Including An Imune Response
GB201400309D0 (en) Predicting Resistance to disease
SG11201608328RA (en) Method for predicting response to therapy for cancer
GB201512609D0 (en) Methods
HK1260665A1 (en) Methods for predicting response to anti-tnf therapy
GB201509493D0 (en) Therapeutic antibody

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)